No

AI Tool Pairs Protein Pathways with Clinical Side Effects, Patient Comorbidities to Suggest Targeted Covid-19 Treatments

A new AI-based “decision prioritization tool” combines data on protein pathways with common Covid-19 side effects and known patient comorbidities to offer possible targeted patient treatment options with existing FDA-approved drugs to help fight Covid-19.